Cue Biopharma, Inc.盘中异动股价大涨5.41%报0.653美元

市场透视2025-11-14

北京时间2025年11月14日23时51分，Cue Biopharma, Inc.（CUE.us）股票出现异动，股价急速上涨5.41%。截至发稿，该股报0.653美元/股，成交量5.404万股，换手率0.07%，振幅6.78%。最近的财报数据显示，该股实现营业收入2.15百万美元，净利润-7.45百万美元，每股收益-0.07美元，毛利2.07百万美元，市盈率-1.41倍。机构评级方面，在所有3家...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2583658089?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-11-14 23:51","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2583658089","market":"us","top_or_hot":-1,"title":"Cue Biopharma, Inc.盘中异动 股价大涨5.41%报0.653美元","media":"市场透视","content":"<div>\n<p>北京时间2025年11月14日23时51分，Cue Biopharma, Inc.（CUE.us）股票出现异动，股价急速上涨5.41%。截至发稿，该股报0.653美元/股，成交量5.404万股，换手率0.07%，振幅6.78%。最近的财报数据显示，该股实现营业收入2.15百万美元，净利润-7.45百万美元，每股收益-0.07美元，毛利2.07百万美元，市盈率-1.41倍。机构评级方面，在所有3家...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142351389504ce3a&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cue Biopharma, Inc.盘中异动 股价大涨5.41%报0.653美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCue Biopharma, Inc.盘中异动 股价大涨5.41%报0.653美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-14 23:51 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142351389504ce3a&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年11月14日23时51分，Cue Biopharma, Inc.（CUE.us）股票出现异动，股价急速上涨5.41%。截至发稿，该股报0.653美元/股，成交量5.404万股，换手率0.07%，振幅6.78%。最近的财报数据显示，该股实现营业收入2.15百万美元，净利润-7.45百万美元，每股收益-0.07美元，毛利2.07百万美元，市盈率-1.41倍。机构评级方面，在所有3家...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142351389504ce3a&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142351389504ce3a&s=b","article_id":"2583658089","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511142351389504ce3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2583658089","pubTimestamp":1763135497,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年11月14日23时51分，Cue Biopharma, Inc.股票出现异动，股价急速上涨5.41%。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Cidara Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cypherpunk Technologies Inc.涨幅较大，Aspire Biopharma Holdings, Inc.、Cypherpunk Technologies Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为911.19%、178.67%、123.05%，振幅较大的相关个股有Cypherpunk Technologies Inc.、Hcw Biologics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为69.31%、59.44%、46.41%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","CUE":"Cue Biopharma, Inc."},"translate_title":"Cue Biopharma, Inc. shares jumped 5.41% to $0.653 in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CUE":1.5},"content_text":"北京时间2025年11月14日23时51分，Cue Biopharma, Inc.（CUE.us）股票出现异动，股价急速上涨5.41%。截至发稿，该股报0.653美元/股，成交量5.404万股，换手率0.07%，振幅6.78%。最近的财报数据显示，该股实现营业收入2.15百万美元，净利润-7.45百万美元，每股收益-0.07美元，毛利2.07百万美元，市盈率-1.41倍。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。Cue Biopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Cidara Therapeutics, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 (To Pur Com)、Cypherpunk Technologies Inc.涨幅较大，Aspire Biopharma Holdings, Inc.、Cypherpunk Technologies Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为911.19%、178.67%、123.05%，振幅较大的相关个股有Cypherpunk Technologies Inc.、Hcw Biologics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 (To Pur Com)，振幅分别为69.31%、59.44%、46.41%。Cue Biopharma, Inc.公司简介：Cue Biopharma Inc 是一家临床阶段的生物制药公司。该公司正在开发一类新型专有生物制剂药物，用于选择性调节人体免疫系统，以治疗多种癌症和自身免疫性疾病。其目标是通过生物候选药物产品平台为癌症和自身免疫性疾病患者提供显著改善的治疗效果。正在筹备中的其他产品包括 CUE-101 作为单一疗法、CUE-101 Pembrolizumab、CUE-102、CUE-103 等。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583658089","isCrawlerRequest":true}

Cue Biopharma, Inc.盘中异动 股价大涨5.41%报0.653美元

精彩评论

Cue Biopharma, Inc.盘中异动股价大涨5.41%报0.653美元